___

• Çetinkaya A, Yılmaz E. Çöpçü reseptörler: özellikleri ve hastalık ilişkileri. Hacettepe Tıp Dergisi 2009; 40 (3): 145
• Kurban S, Mehmetoğlu l. Okside düşük dansiteli lipoprotein otoantikorları ve klinik önemi. Türkiye Klinikleri JMed Sci 2005;25(1):73-84.
• Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T, Onji M. Soluble CDl63 in patients with liver diseases: very high levels of soluble CDl63 in patients with fulminant hepatic failure. J Gastroenterol ;40(1):52-6. Meredith LW, Wilson GK, Fletcher NF, McKeating JA. Hepatitis C virus entry: beyond receptors. Institute for Biomedical Research, University of Birmingham, Birmingham, UK. Rev Med Viral 2012;22(3):182-93.
• Plüddemann A, Neyen C, Gordon S. Macrophage scavenger receptors and host-derived ligands. Methods ;43(3):207-17. WHO: Hepatitis C. Erişim adresi: http://Www.who.int/ mediacentre/factsheets/fs164/en/index.html. Erişim tarihi: 01.05.2013.
• Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci 1979;76(1): 7.
• Nobelprize. Erişim adresizhttp://Www.nobelprize.org/ nobel_prizes/medicine/laureates/1985/Erişim tarihi: 05.2013.
• Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coils. Nature ;343(6258):531-5.
• Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, ProtterAA. CD3 6 is a receptor for oxidized low density lipoprotein. JBiol Chem 1993;268(16):11811-6. ll. Sawamura T, Kume N, Aoyama T, Moriwaki H,
• Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita Greaves DR, Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future Plüddemann A, Mukhopadhyay S, Gordon S. The interaction of macrophage receptors with bacterial ligands. Expert Rev Mol Med 2006;8(28):1-25.
• Wong-Staal F, Syder AJ, McKelvy JF. Targeting HCV entry for development of therapeutics. Viruses Zeisel MB, Fofana I, FaŞ-Kremer S, Baumert TF. Hepatitis C virus entry into hepatocytes: molecular Pavio N, Lai MM. The hepatitis C virus persistence: how to evade the immune system? J Biosci 2003;28(3):287
• Zahid MN, Turek M, Xiao F, Thi VL, Gue'rin M, Fofana I, Bachellier P, Thompson J, Delang L, Neyts J, Bankwitz D, Pietschmann T, Dreux M, Cosset FL, Grunert F,Baumert TF, Zeisel MB. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C Virus infection and viral dissemination. Hepatology 2013;57(2):492-504.
• Benedicto I, Molina-Jimenez F, Garcia-Buey L, Gondar V, Lopez-Cabrera M, Moreno-Otero R, Pedro L. Maj ano. Role of tight junctions in hepatitis C virus infection. Rev Esp Enferm Dig 2012;104(5):255-63.